Search

everythinglearnresearchcommunity

for

Search:↓

Keratosis Pilaris Atrophicans causes skin scarring and might be treated with a new synthetic retinoid.

New treatment improves male hair loss.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Different types of skin pores should be identified correctly and evaluated with suitable methods for reliable results.

Skin grafting can help repigment vitiligo, but it's less effective for widespread cases due to the Koebner phenomenon.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Minoxidil foam enters hair follicles and skin for hair growth.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Researchers found 15 new genetic links to skin traits in Japanese women.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Malassezia-associated dermatitis can cause itching in cats with feline paraneoplastic alopecia.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.